The current study was designed to develop effective diagnostic and prognostic strategies through evaluating the changes in the levels of CTRP3, CTRP9 and MCP-1/CCL2 in females suffering from either T2D only, CAD only, and CAD secondary to T2D. The gene discussed is C1QTNF3; the disease is coronary artery disorder.